Alkermes Inc. plc

ALKSNASDAQUSD
48.37 USD
1.24 (2.50%)AT CLOSE (11:59 AM EDT)
48.36
0.02 (0.03%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
48.36
0.02 (0.03%)
🔴Market: CLOSED

ALKS is currently priced at $48.41. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. On the valuation front, ALKS trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 6, 2026.

Open?$49.61
High?$50.40
Low?$48.21
Prev. Close?$49.61
Volume?1.6M
Avg. Volume?2.2M
VWAP?$48.61
Rel. Volume?0.73x
Bid / Ask
Bid?$40.33 × 100
Ask?$62.70 × 100
Spread?$22.37
Midpoint?$51.52
Valuation & Ratios
Market Cap?8.3B
Shares Out?167.8M
Float?164.0M
Float %?98.4%
P/E Ratio?125.87
P/B Ratio?4.60
EPS?$0.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
8.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
49
Momentum?
8
Short Sent.?
59
Piotroski F-Score?2/9Weak
Altman Z-Score?2.38Grey
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.16%Elevated
Short Interest?15.0M
Days to Cover?9.1
Free Float164.0M
Avg Daily Volume1.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.30Strong
Quick Ratio?1.85Adequate
Cash Ratio?0.77Adequate
Debt/Equity?0.83Moderate
ValuationRICHLY VALUEDvs 4 peers + S&P 500
Score
50/100
P/E?
Peers
25
S&P
3
125.9PRICEY
P/B?
Peers
40
S&P
39
4.60FAIR
P/S?
Peers
60
S&P
29
4.99FAIR
P/FCF?
Peers
25
S&P
19
37.6PRICEY
EV/EBITDA?
Peers
25
S&P
3
45.4HIGH
EV/Sales?
Peers
60
S&P
31
5.59FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
18
3.7%WEAK
ROA?
Peers
50
S&P
16
1.5%WEAK
Cash Flow & Enterprise
FCF?$221.7M
Enterprise Value?$9.3B
Fundamentals ratios updated end of day